Candidacidal mechanisms of peritoneal macrophages activated with lymphokines or gamma-interferon

Journal of Medical Microbiology
E Brummer, D A Stevens

Abstract

The mechanisms by which resident peritoneal macrophages, activated in vitro by lymphokines (LK) or recombinant gamma-interferon (IFN), kill Candida parapsilosis or C. albicans were studied. Resident non-activated peritoneal macrophages killed C. parapsilosis (55.5% SD 6.8%), but not C. albicans. This killing was completely inhibited by superoxide dismutase (SOD), partially by dimethyl sulphoxide (DMSO), but not by catalase or azide. Killing correlated with a brisk lucigenin-dependent chemiluminescence (CL) response by macrophages interacting with C. parapsilosis. No enhanced luminol-dependent CL response was observed in this system. This suggests that C. parapsilosis is killed by resident macrophages via a mechanism dependent on the presence of superoxide anion. By contrast, killing of C. parapsilosis by activated macrophages (49.0% SD 5.9%) was not inhibited by SOD or DMSO, suggesting the induction of a non-oxidative candidacidal mechanism. C. albicans was killed only by macrophages activated with IFN (52.0% SD 3.7%) or LK (55.7% SD 2.8%). Inhibition of killing by SOD was greater in IFN- than in LK-activated macrophages. Conversely, killing by LK-, but not IFN-, activated macrophages was significantly inhibited by catalase, DM...Continue Reading

Citations

Sep 20, 1991·Journal of Immunological Methods·M T ChâteauR Caravano
Jun 1, 1995·FEMS Immunology and Medical Microbiology·A RementeríaM J Sevilla
Jun 17, 1998·Free Radical Biology & Medicine·D A PotokaA S Klein
Mar 20, 2002·Immunology·S ElahiR Clancy
Jan 1, 1990·Journal of Medical and Veterinary Mycology : Bi-monthly Publication of the International Society for Human and Animal Mycology·F de BernardisA Cassone
Aug 13, 2009·Medical Mycology·Jennifer R LindenJoseph M Bliss
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·E W van EttenI A Bakker-Woudenberg
Nov 21, 2013·Revista iberoamericana de micología·José A Martínez-ÁlvarezHéctor M Mora-Montes
Jan 1, 1994·Biotherapy·B J Kullberg, J W van 't Wout
Oct 14, 2009·Critical Reviews in Microbiology·Eveline C van AsbeckDavid A Stevens
May 2, 2008·Pharmacotherapy·John MohrLuis Ostrosky-Zeichner
Jun 10, 2010·FEMS Microbiology Reviews·Frank L van de VeerdonkBart Jan Kullberg
Aug 22, 2006·The Journal of Infectious Diseases·David A StevensKarl V Clemons
Sep 26, 2001·International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity·J A VillenaL Casteilla
Aug 19, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·Katja SeiderBernhard Hube
Jan 27, 2000·Medical Mycology·A J Hamilton, M D Holdom
Dec 1, 1995·Microbiological Reviews·R B Ashman, J M Papadimitriou
Jun 1, 1997·Microbiology and Molecular Biology Reviews : MMBR·A Vázquez-Torres, E Balish

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.